SCNI Scinai Immunotherapeutics
- 3.750
- -0.390-9.42%
- 3.820
- +0.070+1.87%
Scinai Immunotherapeutics News
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Scinai Immunotherapeutics | 424B3: Prospectus
Scinai Immunotherapeutics | 20-F: Registration statement / Annual report / Transition report
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Scinai Immunotherapeutics | NT 20-F: Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Scinai Immunotherapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Daniel E. Stone(12.96%)
Scinai Immunotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Scinai Immunotherapeutics | EFFECT: Others
Scinai Immunotherapeutics | CORRESP: CORRESP
Scinai Immunotherapeutics | UPLOAD: Others
Scinai Immunotherapeutics | F-3: Registration statement for specified transactions by certain foreign private issuers
Scinai Immunotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-DANIEL E. STONE(12.96%)
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Scinai Immunotherapeutics | D: Filing D
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Scinai Immunotherapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Scinai Immunotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Analysis
Price Target
No Data
